Ignite Creation Date:
2024-05-06 @ 4:07 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04878107
Status:
UNKNOWN
Last Update Posted:
2022-05-02
First Post:
2021-05-04
Brief Title:
SBRTLDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1L1 Inhibitor and Chemotherapy
Sponsor:
Wuhan University
Organization:
Wuhan University
Organization Data
Organization:
Wuhan University
Class:
OTHER
Study ID:
2021061
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan University
Lead Sponsor Class:
OTHER
Responsible Party:
Conghua XieMDPhD
Responsible Party Title:
Director of Department of Radiation and Medical Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Wuhan University
Old Name:
None
Old Organization:
None